logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

Results for GSK
David Lewis
16 Apr 14 14:46:21
RT @reutersBenHir: Two more countries added to the list...#GSK says investigating claims of bribery in Jordan, Lebanon http://t.co/rYNbCokG…
Audi Vide Tace
16 Apr 14 13:38:28
$TKMR $OXGN $SYN ..Foresight is Key for These 3 Gems, All Targeting Billion Dollar Markets & Will penetrate With Them With Ease $Roche $GSK
Jackie Highfield
16 Apr 14 13:20:05
$GSK Will Recent News Hurt GlaxoSmithKline? http://t.co/WODVaWkJy5
Informer
16 Apr 14 13:18:36
$GSK: Will Recent News Hurt GlaxoSmithKline? http://t.co/uIEHNpLx8l
Byrne Bray
16 Apr 14 13:11:05
$GSK: Will Recent News Hurt GlaxoSmithKline? http://t.co/lR6CGzKNhM
Byrne Bray
16 Apr 14 13:06:05
$GSK: Will Recent News Hurt GlaxoSmithKline? http://t.co/LrlTFKrE1v
LoveStockNews
16 Apr 14 12:57:07
$GSK - Will Recent News Hurt GlaxoSmithKline? -> http://t.co/hhpuaXyQnL #stock #stocks #stockaction
MarketCurrents
16 Apr 14 12:32:19
GSK adds two more countries to its list http://t.co/tyfWCVuvao $GSK
Jackie Highfield
16 Apr 14 12:30:35
$GSK Dynavax Starts Phase III Study on Heplisav-B http://t.co/6GWa2NOi7u
Jackie Highfield
16 Apr 14 12:25:05
$GSK [$$] Glaxo Examines Bribery Claims http://t.co/6pNk6iyC2y
Jackie Highfield
16 Apr 14 12:19:08
$GSK Dear Jenny McCarthy, Here's How Many Lives Could Be Saved Cheaply By Making Vaccines More Widely Available http://t.co/Y15R8N37ak
stocknews247
16 Apr 14 12:17:06
$GSK - Dynavax Starts Phase III Study on Heplisav-B -> http://t.co/3XqtFYOs4A #stock #stocks #stockaction
Lutz Braune
16 Apr 14 12:13:33
$GSK: Dear Jenny McCarthy, Heres How Many Lives Could Be Saved Cheaply By Ma... http://t.co/mgrVk3ET2i
GavinGreenberg
16 Apr 14 12:12:38
$GSK: [$$] Glaxo Examines Bribery Claims http://t.co/GIQZ6uz7dZ
GavinGreenberg
16 Apr 14 12:07:03
$GSK: Dear Jenny McCarthy, Heres How Many Lives Could Be Saved Cheaply By Ma... http://t.co/2WZVJJUKLR
StockNewsNet
16 Apr 14 12:00:49
$GSK - [$$] Glaxo Examines Bribery Claims -> http://t.co/oGxHVQapao #stock #stocks #stockaction
MarketNews
16 Apr 14 11:55:24
$GSK - Dear Jenny McCarthy, Heres How Many Lives Could Be Saved Cheaply By Ma... -> http://t.co/Joh2YzQpDe #stock #stocks #stockaction
StockNews
16 Apr 14 11:04:11
$GSK - Glaxo Investigating Bribery Claims in Jordan and Lebanon http://t.co/YdIxAAVDMM
Vibeke L. Svansø
16 Apr 14 10:54:17
RT @FiercePharma: Newly minted GlaxoSmithKline #diabetes drug faces formidable foes in GLP-1 market http://t.co/aH0HsVNrE5 $GSK #pharma by …
Media Sentiment
16 Apr 14 10:48:35
$GSK received a new alert. Find out why at http://t.co/WHJp8eTsSr #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 291
Maryjo Craftm
16 Apr 14 10:44:03
$GSK [$$] Glaxo Examines Bribery http://t.co/PU14nHybax
Market Int Center
16 Apr 14 10:42:34
GlaxoSmithKline PLC $GSK Showing Bearish Technicals ( http://t.co/MIdaGTUfmr )
Jennifer Rosales
16 Apr 14 10:37:22
RT @fwpharma: GlaxoSmithKline probes bribery claims in Jordan, Lebanon http://t.co/CtcRZ8hKCP $GSK #pharma
Jackie Highfield
16 Apr 14 10:13:37
$GSK (Video) GlaxoSmithKline plc's Bribery Allegations http://t.co/RCQ0euqqQZ
Audi Vide Tace
16 Apr 14 09:48:59
@Biotech_Boss $CTO Aren't filed for giggles $Roche $GSK $$$$
Audi Vide Tace
16 Apr 14 09:47:42
$OXGN = $Roche $GSK Eye Balling To Swallow This One Up..$TKMR iRNA Therapies Still Will Play Big Market Role Possible acquisition Target $$
Jackie Highfield
16 Apr 14 09:30:11
$GSK GSK says investigating claims of bribery in Jordan, Lebanon http://t.co/6tepWSiBmW
Jackie Highfield
16 Apr 14 09:30:11
$GSK GlaxoSmithKline discloses new bribery inquiries http://t.co/dviHyW2KLi
Jackie Highfield
16 Apr 14 09:30:11
$GSK GlaxoSmithKline discloses new bribery inquiries http://t.co/jkrtHtbrgK
FirstWord Pharma
16 Apr 14 09:29:10
GlaxoSmithKline probes bribery claims in Jordan, Lebanon http://t.co/CtcRZ8hKCP $GSK #pharma
Lutz Braune
16 Apr 14 09:03:34
$GSK: [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon http://t.co/rzeJ6DKj5c
GavinGreenberg
16 Apr 14 09:01:08
$GSK: [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon http://t.co/HU2Q4jFnEY
CWooden
16 Apr 14 08:51:20
:-( "@reutersBenHir: Two more countries added...#GSK says investigating claims of bribery in Jordan, Lebanon http://t.co/dZxcoaOroB $GSK”
Lucy P. Marcus
16 Apr 14 08:50:06
RT @reutersBenHir: Two more countries added to the list...#GSK says investigating claims of bribery in Jordan, Lebanon http://t.co/rYNbCokG…
Ben Hirschler
16 Apr 14 08:49:24
Two more countries added to the list...#GSK says investigating claims of bribery in Jordan, Lebanon http://t.co/rYNbCokGd6 $GSK
Stock Herald
16 Apr 14 08:46:06
$GSK: [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon http://t.co/lkZCq9zN2w
MarketNews
16 Apr 14 08:40:26
$GSK - [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon -> http://t.co/oh2QWdTkuI #stock #stocks #stockaction
Jackie Highfield
16 Apr 14 08:30:52
$GSK [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon http://t.co/6pNk6iyC2y
Jake Mathon
16 Apr 14 07:56:53
RT @CitelineCydneyB: #FDA approves $GSK #Tanzeum for #diabetes. Have you been following #albiglutide #clinicaltrials? #biopharma @citeline …
Colin White
16 Apr 14 06:31:36
RT @ScripDonnaDC: ICYMI: GSK GLP-1 Tanzeum OK'd in US; Now what? http://t.co/CDc930I5Rx #pharma #biotech #biopharma #diabetes #albiglutide…
RevolutionaryTrading
16 Apr 14 06:10:19
Tom's tweets - Long watch $YHOO $GMCR $JNJ $YELP $SFUN $XIV $PNC $BA $LVS $TSLA $YOKU $GSK
Citeline
16 Apr 14 05:40:06
RT @CitelineCydneyB: #FDA approves $GSK #Tanzeum for #diabetes. Have you been following #albiglutide #clinicaltrials? #biopharma @citeline …
Fergus Hillo
16 Apr 14 05:34:05
$GSK 2:28 pm GlaxoSmithKline receives US appro http://t.co/X7w0mMzoDF
Cydney Brooks
16 Apr 14 05:17:03
#FDA approves $GSK #Tanzeum for #diabetes. Have you been following #albiglutide #clinicaltrials? #biopharma @citeline http://t.co/Fr95fOdNCr
Reverse Diabetes
16 Apr 14 05:01:16
RT @ScripDonnaDC: ICYMI: GSK GLP-1 Tanzeum OK'd in US; Now what? http://t.co/CDc930I5Rx #pharma #biotech #biopharma #diabetes #albiglutide…
Mary Studebaker
16 Apr 14 04:55:04
RT @ScripDonnaDC: ICYMI: GSK GLP-1 Tanzeum OK'd in US; Now what? http://t.co/CDc930I5Rx #pharma #biotech #biopharma #diabetes #albiglutide…
Industry Pharmacists
16 Apr 14 04:34:57
RT @fwpharma: FDA clears GlaxoSmithKline's #diabetes therapy Tanzeum http://t.co/YSnKGghlU8 $GSK #pharma
MAISA
16 Apr 14 04:32:10
$GSK_$52.32_FDA has approved Tanzeum™ (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes
Informer
16 Apr 14 04:12:45
$GSK: (Video) GlaxoSmithKline plcs Bribery Allegations http://t.co/lot425jE3b
markaodonnell
16 Apr 14 04:12:21
RT @ScripDonnaDC: ICYMI: GSK GLP-1 Tanzeum OK'd in US; Now what? http://t.co/CDc930I5Rx #pharma #biotech #biopharma #diabetes #albiglutide…
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.